Capsule
TALZENNA CAPSULES 0.25MG
Summary
TALZENNA CAPSULES 0.25MG — Capsule containing talazoparib (as tosylate). Hong Kong Registration No. HK-66589. Certificate Holder: PFIZER CORPORATION HONG KONG LIMITED. Date of Registration: 06 Mar, 2020.
Product NameTALZENNA CAPSULES 0.25MG
Registration No.HK-66589
Certificate HolderPFIZER CORPORATION HONG KONG LIMITED
Holder Address21/F, KERRY CENTRE, 683, KING'S ROAD, QUARRY BAY, HONG KONG
Ingredientstalazoparib (as tosylate)
Dosage FormCapsule
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration06 Mar, 2020
ATC codesL01XK04
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。